This is an article published in the French biotech press. Some people have changed, and we’re now planning to enter the clinical phase, but all the rest is still up to date (here).
Strasbourg welcomes a new start-up in its land of scientific excellence: LAMINA THERAPEUTICS, based on an innovative technology emerging from INSERM and the University of Strasbourg, and supported by SATT CONECTUS. This start-up is developing a new generation of implantable medical devices for regenerative medicine. A promising breakthrough innovation, which could open up new therapeutic […]